Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 44 | 2024 | 13104 | 1.510 |
Why?
|
Early Detection of Cancer | 16 | 2024 | 3086 | 0.920 |
Why?
|
Solitary Pulmonary Nodule | 4 | 2023 | 266 | 0.920 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 22 | 2021 | 5223 | 0.800 |
Why?
|
Multiple Pulmonary Nodules | 2 | 2022 | 153 | 0.680 |
Why?
|
Quality Assurance, Health Care | 4 | 2019 | 2212 | 0.530 |
Why?
|
Medical Oncology | 5 | 2024 | 2267 | 0.500 |
Why?
|
Telephone | 1 | 2018 | 617 | 0.490 |
Why?
|
Neoplasms | 13 | 2024 | 21696 | 0.450 |
Why?
|
Smoking Cessation | 3 | 2021 | 2071 | 0.410 |
Why?
|
Survivors | 4 | 2016 | 2291 | 0.370 |
Why?
|
Fear | 2 | 2016 | 1440 | 0.350 |
Why?
|
Medication Errors | 1 | 2016 | 798 | 0.350 |
Why?
|
Telemedicine | 2 | 2024 | 2872 | 0.340 |
Why?
|
Palliative Care | 8 | 2024 | 3493 | 0.320 |
Why?
|
Smoking | 4 | 2021 | 8987 | 0.300 |
Why?
|
Comprehension | 1 | 2012 | 610 | 0.290 |
Why?
|
Patient Care Planning | 1 | 2012 | 921 | 0.290 |
Why?
|
Tomography, X-Ray Computed | 13 | 2022 | 20130 | 0.280 |
Why?
|
Medication Adherence | 4 | 2020 | 2063 | 0.280 |
Why?
|
Health Services Accessibility | 3 | 2021 | 5135 | 0.260 |
Why?
|
Mental Health Services | 1 | 2016 | 1644 | 0.250 |
Why?
|
Quality Improvement | 3 | 2019 | 3749 | 0.230 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13693 | 0.230 |
Why?
|
Mass Screening | 5 | 2022 | 5253 | 0.210 |
Why?
|
Quality Indicators, Health Care | 2 | 2019 | 1831 | 0.190 |
Why?
|
Humans | 75 | 2024 | 744366 | 0.180 |
Why?
|
Terminal Care | 5 | 2015 | 1694 | 0.180 |
Why?
|
Surge Capacity | 1 | 2020 | 42 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2016 | 9240 | 0.180 |
Why?
|
Practice Guidelines as Topic | 6 | 2021 | 7282 | 0.180 |
Why?
|
Thymus Neoplasms | 2 | 2013 | 268 | 0.170 |
Why?
|
Middle Aged | 39 | 2022 | 213390 | 0.170 |
Why?
|
Resorcinols | 1 | 2018 | 38 | 0.160 |
Why?
|
Incidental Findings | 2 | 2020 | 689 | 0.160 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3395 | 0.160 |
Why?
|
Quality of Life | 10 | 2021 | 12802 | 0.160 |
Why?
|
Isoxazoles | 1 | 2018 | 216 | 0.150 |
Why?
|
Documentation | 2 | 2014 | 871 | 0.150 |
Why?
|
Uncertainty | 2 | 2022 | 735 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2018 | 220 | 0.140 |
Why?
|
Acrylamides | 1 | 2018 | 255 | 0.140 |
Why?
|
Reminder Systems | 1 | 2020 | 371 | 0.140 |
Why?
|
Aged | 31 | 2022 | 163288 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2023 | 975 | 0.140 |
Why?
|
Health Behavior | 2 | 2018 | 2635 | 0.140 |
Why?
|
Mass Chest X-Ray | 1 | 2015 | 16 | 0.140 |
Why?
|
Physicians, Primary Care | 1 | 2022 | 592 | 0.130 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 655 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3020 | 0.130 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2018 | 434 | 0.130 |
Why?
|
Female | 44 | 2022 | 380193 | 0.130 |
Why?
|
Pandemics | 4 | 2024 | 8385 | 0.130 |
Why?
|
Cancer Care Facilities | 2 | 2018 | 402 | 0.130 |
Why?
|
Male | 40 | 2023 | 350115 | 0.120 |
Why?
|
Health Communication | 1 | 2018 | 214 | 0.120 |
Why?
|
Terminally Ill | 2 | 2014 | 238 | 0.120 |
Why?
|
Patient Selection | 3 | 2021 | 4216 | 0.120 |
Why?
|
Thymoma | 2 | 2013 | 186 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2021 | 57776 | 0.120 |
Why?
|
Hospital Rapid Response Team | 1 | 2014 | 57 | 0.120 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2016 | 255 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 4 | 2021 | 5534 | 0.120 |
Why?
|
Aniline Compounds | 1 | 2018 | 986 | 0.120 |
Why?
|
Triage | 1 | 2020 | 977 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11525 | 0.120 |
Why?
|
Puerperal Disorders | 1 | 2016 | 275 | 0.110 |
Why?
|
Massachusetts | 4 | 2021 | 8662 | 0.110 |
Why?
|
Radiology Information Systems | 1 | 2017 | 523 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 796 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2019 | 1094 | 0.110 |
Why?
|
Lung | 4 | 2022 | 9857 | 0.110 |
Why?
|
Administration, Oral | 5 | 2020 | 3914 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2022 | 2987 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 941 | 0.110 |
Why?
|
Risk Management | 1 | 2016 | 571 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
Clinical Coding | 1 | 2013 | 171 | 0.100 |
Why?
|
Mediastinum | 1 | 2012 | 267 | 0.090 |
Why?
|
Withholding Treatment | 1 | 2015 | 599 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1581 | 0.090 |
Why?
|
Appointments and Schedules | 1 | 2014 | 417 | 0.090 |
Why?
|
Health Promotion | 1 | 2022 | 2205 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2016 | 1095 | 0.090 |
Why?
|
Neoplasm Staging | 6 | 2021 | 11031 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2133 | 0.080 |
Why?
|
Patient Education as Topic | 2 | 2015 | 2278 | 0.080 |
Why?
|
Adult | 19 | 2023 | 214052 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2014 | 1461 | 0.080 |
Why?
|
Pilot Projects | 2 | 2018 | 8319 | 0.080 |
Why?
|
Self Report | 4 | 2022 | 3553 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2213 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2265 | 0.070 |
Why?
|
Forecasting | 2 | 2015 | 2951 | 0.070 |
Why?
|
Pleural Neoplasms | 1 | 2012 | 607 | 0.070 |
Why?
|
Self Concept | 1 | 2012 | 1025 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20824 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1438 | 0.070 |
Why?
|
Patient Care Management | 1 | 2009 | 306 | 0.070 |
Why?
|
Genotype | 4 | 2016 | 12952 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 5172 | 0.070 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7785 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2013 | 990 | 0.070 |
Why?
|
Mesothelioma | 1 | 2012 | 818 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2760 | 0.060 |
Why?
|
Neoplasm Metastasis | 5 | 2015 | 4851 | 0.060 |
Why?
|
Health Care Surveys | 3 | 2019 | 2453 | 0.060 |
Why?
|
Outpatients | 1 | 2013 | 1487 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2052 | 0.060 |
Why?
|
Stress, Psychological | 2 | 2017 | 4245 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2022 | 77460 | 0.060 |
Why?
|
Boston | 2 | 2016 | 9312 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 1972 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 840 | 0.060 |
Why?
|
Electronic Health Records | 5 | 2022 | 4468 | 0.060 |
Why?
|
Prognosis | 8 | 2018 | 29060 | 0.060 |
Why?
|
Pyridines | 1 | 2014 | 2825 | 0.050 |
Why?
|
Survival Rate | 4 | 2019 | 12788 | 0.050 |
Why?
|
Radiotherapy | 1 | 2009 | 1533 | 0.050 |
Why?
|
Primary Health Care | 2 | 2016 | 4557 | 0.050 |
Why?
|
Hospitalization | 2 | 2022 | 10259 | 0.050 |
Why?
|
Risk Assessment | 4 | 2019 | 23336 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Referral and Consultation | 3 | 2021 | 3531 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2727 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2021 | 1660 | 0.050 |
Why?
|
Pain | 1 | 2016 | 4988 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2021 | 9955 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3229 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12244 | 0.050 |
Why?
|
Ritonavir | 1 | 2022 | 322 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5321 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3480 | 0.050 |
Why?
|
Hotlines | 1 | 2020 | 55 | 0.050 |
Why?
|
Radiation Dosage | 2 | 2020 | 1928 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11366 | 0.050 |
Why?
|
Communication | 1 | 2014 | 3750 | 0.050 |
Why?
|
Health Status | 1 | 2014 | 4034 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7658 | 0.050 |
Why?
|
Attitude to Death | 1 | 2003 | 382 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2012 | 3476 | 0.050 |
Why?
|
Carbazoles | 1 | 2021 | 226 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2011 | 2690 | 0.040 |
Why?
|
Time Factors | 4 | 2015 | 40075 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15535 | 0.040 |
Why?
|
United States | 8 | 2022 | 69872 | 0.040 |
Why?
|
Cohort Studies | 5 | 2022 | 40559 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2012 | 3747 | 0.040 |
Why?
|
Triazines | 1 | 2021 | 315 | 0.040 |
Why?
|
Psychometrics | 2 | 2017 | 3003 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 3922 | 0.040 |
Why?
|
Affect | 2 | 2017 | 1475 | 0.040 |
Why?
|
Perception | 2 | 2016 | 1198 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2012 | 602 | 0.040 |
Why?
|
Depression | 2 | 2015 | 7759 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 578 | 0.040 |
Why?
|
Physicians | 1 | 2014 | 4567 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 1958 | 0.030 |
Why?
|
Advance Care Planning | 1 | 2003 | 662 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1379 | 0.030 |
Why?
|
Peripartum Period | 1 | 2016 | 133 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2018 | 25039 | 0.030 |
Why?
|
Comorbidity | 3 | 2016 | 10388 | 0.030 |
Why?
|
Imidazoles | 1 | 2021 | 1206 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 911 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2011 | 4639 | 0.030 |
Why?
|
Professional Autonomy | 1 | 2014 | 177 | 0.030 |
Why?
|
Piperidines | 1 | 2021 | 1602 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 574 | 0.030 |
Why?
|
Prescriptions | 1 | 2015 | 387 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19905 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1364 | 0.030 |
Why?
|
Decision Making | 2 | 2018 | 3888 | 0.030 |
Why?
|
Exons | 1 | 2018 | 2439 | 0.030 |
Why?
|
Guanine | 1 | 2013 | 274 | 0.030 |
Why?
|
Glutamates | 1 | 2013 | 398 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.030 |
Why?
|
Radiology | 2 | 2016 | 2099 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2013 | 408 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 397 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 56429 | 0.020 |
Why?
|
Electronic Mail | 1 | 2013 | 213 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1179 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39052 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.020 |
Why?
|
Survival Analysis | 2 | 2014 | 10252 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3508 | 0.020 |
Why?
|
Mutation | 4 | 2018 | 29786 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1265 | 0.020 |
Why?
|
Phobic Disorders | 1 | 2011 | 439 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2011 | 812 | 0.020 |
Why?
|
Hospice Care | 1 | 2015 | 672 | 0.020 |
Why?
|
Patient Preference | 1 | 2014 | 889 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 738 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1356 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2488 | 0.020 |
Why?
|
Research | 1 | 2015 | 1999 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 13882 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1164 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7914 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 783 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2971 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1530 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5388 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 63107 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
Risk Factors | 3 | 2018 | 72296 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
Insurance, Health | 1 | 2017 | 2494 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12961 | 0.020 |
Why?
|
Health Expenditures | 1 | 2017 | 2349 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2924 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6311 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3154 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 20952 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3743 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6194 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6896 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4034 | 0.010 |
Why?
|
Education, Medical | 1 | 2014 | 1722 | 0.010 |
Why?
|
Health Personnel | 1 | 2015 | 3219 | 0.010 |
Why?
|
Data Collection | 1 | 2011 | 3339 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16690 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2015 | 5316 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6539 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6364 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3841 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8340 | 0.010 |
Why?
|
Anxiety | 1 | 2015 | 4293 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2725 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13286 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8091 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7730 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
Spirituality | 1 | 2003 | 405 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9849 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14723 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10400 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53290 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12356 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13409 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2003 | 2539 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18373 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15221 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29144 | 0.010 |
Why?
|
Social Support | 1 | 2003 | 2118 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17446 | 0.010 |
Why?
|